Whether the public procurement policy can increase R&D innovation in the pharmaceutical enterprises
- DOI
- 10.2991/978-94-6463-326-9_6How to use a DOI?
- Keywords
- Public procurement policy; Pharmaceutical enterprises; R&D investment; Regression discontinuity design
- Abstract
In November 2018, with the implementation of drug quantity Purchase in ‘4 + 7’ pilot cities, China‘s drug purchase system stepped into a new level. With the continuous advancement of China‘s drug public procurement policy, the situation of the pharmaceutical industry has changed tremendously. The days when companies rely on generic drugs to obtain high profits are gone, and innovation has become the only way for pharmaceutical companies to develop. By selecting the data of listed companies in the pharmaceutical industry from 2015 to 2021 as a sample, this paper uses the SRD to study the correlation between the drug public procurement policy and the R&D innovation of the pharmaceutical enterprises. And the empirical result shows that the public procurement policy has a positive effect on them, and it is still established after a series of robustness tests. Based on the results, we put forward some policy recommendations.
- Copyright
- © 2023 The Author(s)
- Open Access
- Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
Cite this article
TY - CONF AU - Jianqun Wu PY - 2023 DA - 2023/12/30 TI - Whether the public procurement policy can increase R&D innovation in the pharmaceutical enterprises BT - Proceedings of the 2023 3rd International Conference on Business Administration and Data Science (BADS 2023) PB - Atlantis Press SP - 51 EP - 60 SN - 2589-4900 UR - https://doi.org/10.2991/978-94-6463-326-9_6 DO - 10.2991/978-94-6463-326-9_6 ID - Wu2023 ER -